Results 241 to 250 of about 125,944 (285)

HLA-DR-Expressing Fibroblast-Like Synoviocytes Are Inducible Antigen Presenting Cells That Present Autoantigens in Lyme Arthritis. [PDF]

ACR Open Rheumatol
Rouse JR, Danner R, Wahhab A, Pereckas M, Nguyen C, McClune ME, Steere AC, Strle K, Jutras BL, Lochhead RB.   +9 more
europepmc   +1 more source

HIV co-infection is associated with increased HLA-DR expression by Mycobacterium tuberculosis-specific CD4 T cells in people with latent tuberculosis infection. [PDF]

Tuberculosis (Edinb)
Khayumbi J, Sasser LE, McLaughlin TA, Ongalo J, Tonui J, Ouma SG, Campbell A, Odhiambo FH, Gandhi NR, Kiprotich C, Day CL.   +10 more
europepmc   +1 more source

The role of products of the human HLA-DR locus (Ia molecules) in in vitro M. leprae driven lymphoproliferation.

, 1983
Abebe Haregewoin, T Yemaneberhan, A Belehu   +2 more
openalex   +1 more source

ANXA10 sensitizes microsatellite instability-high colorectal cancer to anti-PD-1 immunotherapy via assembly of HLA-DR dimers by regulating CD74. [PDF]

Cell Biol Toxicol
Sun Y, Yang B, Wen T, Guo X, Li D, Shi R, Zhang F, Wang D, Li C, Qu X.   +9 more
europepmc   +1 more source

Mediating role of chiro-inositol metabolites on the effects of HLA-DR-expressing CD14 + monocytes in inflammatory bowel disease. [PDF]

BMC Gastroenterol
Zhang L, Shen P, Ge W, Liao W, Luo Q, Li C, Zhan C, Yuan X, Zhang X, Yan X.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Targeting HLA-DR

Leukemia & Lymphoma, 2009
The MHC class II human leukocyte antigens (HLAs) are 60-kDa transmembrane αβ heterodimers expressed on the cell surface of antigen presenting cells.
Kevin, Tay, Kieron, Dunleavy, Wyndham H, Wilson   +2 more
openaire   +2 more sources

???????????????????? ?????????????????? HLA-DR ??????????????????, ???????????? ???????????????????????????????????? ?????????????????????? ?? ?????????????????????????????? ?????????????????? ???????????????????? ???????????? ?????? ??????????????????

2019
???????? ?????????????????????????? ???????????????? ????????????????, ?????? ?????????????????? ?????????? ???????????????????? ???????????? ?????? ??????????????????, ???? ?????????? ???? ??????????????. ?? ???????????? ???????????????????????? ?????????????? ?????????????????? ?????????????????? ???????????????????????? HLA-DR ?? ????????????????????
H. Renz, B. Gierten
openaire   +3 more sources

HLA-DR meets ERK

Blood, 2010
In this issue of Blood, Stein and colleagues present a novel mechanism by which MHC class II antibodies induce apoptosis in lymphoid malignancies. These are important findings that provide fresh insight into a common antibody target.
Erin, Hertlein, John C, Byrd
openaire   +2 more sources

HLA-DR is a procoagulant

Biochemical and Biophysical Research Communications, 1991
Numerous incidents of thromboembolic complications have been documented in cancer patients and in recipients of mismatched organ transplants. Tumor procoagulants have also been implicated in the process of metastasis. Two protein bands of 35,000 and 28,000 daltons isolated from human ovarian carcinoma possessed procoagulant activity.
M, Chelladurai, K V, Honn, D A, Walz
openaire   +2 more sources

HLA-DR TYPING BY RADIOIMMUNOASSAY

Transplantation, 1980
A radioimmunoassay procedure is described by which peripheral blood lymphocytes can be typed for HLA-DR specificities. The major advantages of this method are the following: simple and reproducible procedure, no need for B lymphocyte separation, no need for optimal viability, and no need for preabsorption of antisera with platelets.
R, Tosi, N, Tanigaki, D, Centis, P L, Rossi, G, Alfano, G B, Ferrara, D, Pressman   +6 more
openaire   +2 more sources